Literature DB >> 34777866

Egyptian protocol for living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic.

Hany Said Abd Elbaset1, Ahmad Mohammad Sultan2, Iman Fawzy Montasser3, Hossam E M Soliman4, Mohamed Elayashy5, Nahed A Makhlouf6.   

Abstract

BACKGROUND: The current SARS-CoV-2 pandemic may negatively impact the care of liver transplant candidates and recipients. MAIN BODY OF THE ABSTRACT: Accordingly, each country must have its national guidelines based on the current situation and according to available tools. Liver Transplantation Scientific Committee of Waiting List Project in Egypt was established in 13 April 2020. One of the major objectives of this Scientific Committee is the preparation of national protocol for Transplant Centers in Egypt to deal with living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic.
CONCLUSIONS: The protocol highlights basic hospital requirements for LDLT during SARS-CoV-2 pandemic, the patient selection from the waiting list, management of patients on the waiting list, and post-transplant management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43066-020-00074-4.
© The Author(s) 2021.

Entities:  

Keywords:  Egyptian national protocol; LDLT; SARS-CoV-2; Waiting list project

Year:  2021        PMID: 34777866      PMCID: PMC7871952          DOI: 10.1186/s43066-020-00074-4

Source DB:  PubMed          Journal:  Egypt Liver J        ISSN: 2090-6218


  9 in total

Review 1.  Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.

Authors:  Agustín Albillos; Margaret Lario; Melchor Álvarez-Mon
Journal:  J Hepatol       Date:  2014-08-15       Impact factor: 25.083

2.  Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.

Authors:  Lorenzo D'Antiga
Journal:  Liver Transpl       Date:  2020-04-24       Impact factor: 5.799

Review 3.  Living donor liver transplantation in Egypt.

Authors:  Khaled E Amer; Ibrahim Marwan
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

4.  Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19.

Authors:  Poramed Winichakoon; Romanee Chaiwarith; Chalerm Liwsrisakun; Parichat Salee; Aree Goonna; Atikun Limsukon; Quanhathai Kaewpoowat
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

5.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 6.  Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.

Authors:  Tobias Boettler; Philip N Newsome; Mario U Mondelli; Mojca Maticic; Elisa Cordero; Markus Cornberg; Thomas Berg
Journal:  JHEP Rep       Date:  2020-04-02

7.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

8.  Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.

Authors:  Lan Zhu; Xizhen Xu; Ke Ma; Junling Yang; Hanxiong Guan; Song Chen; Zhishui Chen; Gang Chen
Journal:  Am J Transplant       Date:  2020-03-31       Impact factor: 8.086

9.  Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.

Authors:  Oren K Fix; Bilal Hameed; Robert J Fontana; Ryan M Kwok; Brendan M McGuire; David C Mulligan; Daniel S Pratt; Mark W Russo; Michael L Schilsky; Elizabeth C Verna; Rohit Loomba; David E Cohen; Jorge A Bezerra; K Rajender Reddy; Raymond T Chung
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.298

  9 in total
  1 in total

1.  Albuminuria as a predictor of mortality in type II diabetic patients after living-donor liver transplantation.

Authors:  Ahmed Abdallah Salman; Mohamed Abdalla Salman; Mostafa Said; Hesham Elkassar; Mohammad El Sherbiny; Ahmed Youssef; Mohammed Elbaz; Ahmed M Elmeligui; Mohamed Badr Hassan; Mahmoud Gouda Omar; Hussien Samir; Mohamed Abdelkader Morad; Hossam El-Din Shaaban; Mohamed Youssef; Ahmed Moustafa; Mohamed Sabry Tourky; Ahmed Elewa; Sadaf Khalid; Khaled Monazea; Mohamed Shawkat
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.